FMI opines the subcutaneous bispecific antibody auto-injectors market was valued at USD 24.2 million in 2025. Demand is expected to reach USD 30.0 million in 2026. Hematologic malignancies are estimated to lead the Therapeutic Area with 48.6% share in 2026 and Disposable spring-driven auto-injectors are projected to dominate by Device Format through the forecast period.